Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $60,632. The most recent transaction as insider was on Aug 22, 2024, when has been sold 3,600 shares (Common Stock) at a price of $348.1 per share, resulting in proceeds of $1,253,160. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130

0% 3M change

0% 12M change

Total Value Held $60,632

MARTINE A ROTHBLATT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 22 2024	SELL Open market or private sale	$1,253,160 $348.1 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 22 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 21 2024	SELL Open market or private sale	$1,260,072 $350.02 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 21 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 20 2024	SELL Open market or private sale	$1,250,964 $347.49 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 20 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 19 2024	SELL Open market or private sale	$1,226,484 $340.69 p/Share	3,600 Reduced 96.51%	130 Common Stock

Aug 19 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 16 2024	SELL Open market or private sale	$1,153,296 $320.36 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 16 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 15 2024	SELL Open market or private sale	$1,165,824 $323.84 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 14 2024	SELL Open market or private sale	$1,171,476 $325.41 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 14 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 13 2024	SELL Open market or private sale	$1,185,912 $329.42 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 13 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 12 2024	SELL Open market or private sale	$1,199,916 $333.31 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 12 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 09 2024	SELL Open market or private sale	$1,190,376 $330.66 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 09 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 08 2024	SELL Open market or private sale	$1,180,116 $327.81 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 08 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 07 2024	SELL Open market or private sale	$1,168,200 $324.5 p/Share	3,600 Reduced 96.51%	130 Common Stock
Aug 07 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Aug 06 2024	SELL Open market or private sale	$1,171,368 $325.38 p/Share	3,600 Reduced 96.51%	130 Common Stock

MAR

Martine A Rothblatt

Chairperson & CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account